The Patent Finder

Compositions, Imaging, and Therapeutic Methods Targeting Folate Receptor 1 (FOLR1)

Indi Molecular, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,733,246Compositions, Imaging, and Therapeutic Methods Targeting Folate Receptor 1 (FOLR1)
In force
 · Low confidence
Indi Molecular, Inc.In forceLow confidence
Application 18/453,159Compositions, Imaging, and Therapeutic Methods Targeting Folate Receptor 1 (FOLR1)
Abandoned
Abandoned Nov 9, 2026
Indi Molecular, Inc.AbandonedAbandoned Nov 9, 2026
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Indi Molecular, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited